From: Retrospective analysis of 119 Chinese noninflammatory locally advanced breast cancer cases treated with intravenous combination of vinorelbine and epirubicin as a neoadjuvant chemotherapy: a median follow-up of 63.4 months
Toxicity
No.
%
Neutropenia
55
46.2%
Anemia
---
Thrombocytopenia
2
1.7%
Alopecia
76
63.9%
Nausea/vomiting
15
12.6%
Mucositis
5
4.2%
Hepatic function
3
2.5%
Neuropathy
Cardiac function